Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1083.0000 -17.90 (-1.63%)

NSE Jan 09, 2026 15:31 PM

New 52W High in past week

Volume: 1.6M

Laurus Labs Ltd.

29 Jan 2022

1083.00

-1.63%

Laurus Labs (HOLD): PAT declines 44% on negative operating leverage

Hold: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Inventory destocking in ARV API/FDF led to 20% YoY decline in revenue; guided to normalise from Q4

Laurus Labs Ltd. has an average target of 888.00 from 5 brokers.